Wettstein P J, Haughton G, Frelinger J A
J Exp Med. 1977 Nov 1;146(5):1346-55. doi: 10.1084/jem.146.5.1346.
Genes in the H-2 complex regulate the relative immunogenicity of the H-7.1 histocompatibility alloantigen, as measured by survival times of H-7.1-incompatible skin grafts in vivo. The gene controlling relative rejectability of H-7.1-incompatible grafts has been mapped to the H-2D region. H-7.1-incompatible skin grafts donated by H-2Db donors were rejected significantly more rapidly by H-2a/H-2b heterozygous recipients than similar H-7.1-incompatible grafts donated by H-2Dd donors. Further, there was absolutely no evidence of H-2 restriction in cytotoxic effector activity. In vivo cross-priming, as indicated by accelerated secondary graft rejection, was extensive. The efficiency of cross-priming was dependent upon the primary and secondary graft donor H-2 haplotypes.
H-2复合体中的基因调节H-7.1组织相容性同种异体抗原的相对免疫原性,这通过体内H-7.1不相容皮肤移植物的存活时间来衡量。控制H-7.1不相容移植物相对排斥性的基因已被定位到H-2D区域。H-2Db供体捐赠的H-7.1不相容皮肤移植物被H-2a/H-2b杂合受体排斥的速度明显快于H-2Dd供体捐赠的类似H-7.1不相容移植物。此外,在细胞毒性效应活性方面完全没有H-2限制的证据。如加速的二次移植物排斥所示,体内交叉启动广泛存在。交叉启动的效率取决于初次和二次移植物供体的H-2单倍型。